Who Owns Jade Biosciences Stock?
NASDAQ: JBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 118.32%
- Institutions (% of float)
- 119.19%
- Held by insiders
- 0.73%
- Institutional holders
- 222
- Institutions 99.3%
- Insiders 0.7%
- Public and other 0.0%
Who owns Jade Biosciences stock?
Institutional investors own about 118.3% of Jade Biosciences's shares, spread across 222 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.73% of JBIO.
The largest institutional holders are FMR, LLC (14.18%), Janus Henderson Group Ltd. (10.11%) and Paradigm Biocapital Advisors LP (8.75%). Together, the top 10 institutions control 68.0% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their JBIO positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of JBIO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 9.81M | 14.18% | +7.5% |
| Janus Henderson Group Ltd. | 6.99M | 10.11% | +125.1% |
| Paradigm Biocapital Advisors LP | 6.05M | 8.75% | +111.8% |
| Fairmount Funds Management LLC | 4.55M | 6.58% | 0.0% |
| Bellevue Group AG | 4.29M | 6.21% | +40.4% |
| Franklin Templeton, Inc. | 3.81M | 5.50% | +36.4% |
| Blackrock Inc. | 3.37M | 4.87% | +20.2% |
| Venrock Adviser, LLC | 3.22M | 4.65% | 0.0% |
| State Street Corporation | 2.60M | 3.76% | +11.5% |
| Vanguard Capital Management LLC | 2.35M | 3.39% | +4.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of JBIO
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.71M | 2.48% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.70M | 2.46% |
| Franklin Value Investors Trust-FRANKLIN SMALL CAP VALUE FUND | 1.41M | 2.04% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.19M | 1.72% |
| iShares Trust-iShares Russell 2000 ETF | 1.03M | 1.49% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.00M | 1.45% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 987.89K | 1.43% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 960.97K | 1.39% |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 908.15K | 1.31% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 779.91K | 1.13% |
Frequently asked questions
Who is the largest shareholder of Jade Biosciences?
FMR, LLC is the largest institutional shareholder of JBIO, owning 14.18% of shares outstanding (9.81M shares) as of its latest 13F filing.
What percentage of Jade Biosciences is owned by institutions?
Institutions own about 118.3% of JBIO shares and 119.2% of the public float.
How much of Jade Biosciences do insiders own?
Insiders, such as officers and directors, own about 0.73% of JBIO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.